Dongquan Shi Selected Research

niobium carbide

2/2022

Niobium carbide (MXene) reduces UHMWPE particle-induced osteolysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dongquan Shi Research Topics

Disease

15	Osteoarthritis 12/2022 - 01/2006
15	Venous Thrombosis (Deep-Vein Thrombosis) 02/2018 - 10/2012
11	Knee Osteoarthritis 01/2021 - 01/2006
4	Inflammation (Inflammations) 12/2022 - 02/2018
3	Pain (Aches) 12/2022 - 03/2017
3	Thrombosis (Thrombus) 01/2020 - 01/2013
3	Venous Thromboembolism 04/2016 - 01/2014
2	Stress Fractures (Stress Fracture) 01/2022 - 02/2015
2	Atherosclerosis 01/2022 - 07/2021
2	Osteoporosis 01/2020 - 01/2019
2	Bone Fractures (Bone Fracture) 07/2019 - 01/2019
2	Pulmonary Embolism 04/2016 - 02/2015
2	Congenital Hip Dislocation 01/2011 - 01/2008
1	Gout 12/2022
1	Edema (Dropsy) 12/2022
1	Osteolysis 02/2022
1	Hypersensitivity (Allergy) 07/2021
1	Tendinopathy (Tendonitis) 01/2021
1	Osteophyte 01/2021
1	Synovitis 01/2021
1	Poisoning 06/2020
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020
1	Sleep Deprivation 07/2019
1	Osteochondrodysplasias (Spondyloepiphyseal Dysplasia) 08/2018
1	Postmenopausal Osteoporosis 04/2018
1	Hemorrhage 11/2017
1	Congenital Abnormalities (Deformity) 07/2017
1	Neoplasms (Cancer) 03/2017
1	Mental Disorders (Mental Disorder) 01/2017
1	Osteonecrosis (Kienbock's Disease) 03/2016
1	of childhood progressive pseudorheumatoid Arthropathy 01/2016
1	Rare Diseases (Rare Disease) 01/2016

Drug/Important Bio-Agent (IBA)

4	Therapeutic UsesIBA 01/2022 - 01/2019
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 01/2013
3	fibrin fragment D (D-dimer)IBA 04/2020 - 07/2013
3	Biomarkers (Surrogate Marker)IBA 02/2018 - 10/2012
3	Aspartic Acid (Aspartate)FDA Link 02/2011 - 01/2006
2	EnzymesIBA 12/2022 - 05/2018
2	CytokinesIBA 02/2022 - 05/2018
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	LeptinIBA 01/2021 - 10/2010
2	OsteoprotegerinIBA 01/2020 - 10/2017
2	AnticoagulantsIBA 01/2020 - 12/2013
2	Heparin (Liquaemin)FDA LinkGeneric 01/2020 - 08/2018
2	TrehaloseIBA 01/2020 - 07/2019
2	5' Untranslated Regions (5' UTR)IBA 05/2008 - 04/2007
1	Uric Acid (Urate)IBA 12/2022
1	Urate Oxidase (Uricase)IBA 12/2022
1	CatalaseIBA 12/2022
1	niobium carbideIBA 02/2022
1	MXeneIBA 02/2022
1	ultra-high molecular weight polyethylene (UHMWPE)IBA 02/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Arginine (L-Arginine)FDA Link 01/2022
1	Uridine PhosphorylaseIBA 01/2022
1	SHP099IBA 01/2022
1	UridineIBA 01/2022
1	betadex (beta-cyclodextrin)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 07/2021
1	andrographolideIBA 07/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2021
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 07/2021
1	CationsIBA 01/2021
1	OsteopontinIBA 01/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2021
1	Capsaicin (Zostrix)FDA Link 01/2021
1	chromium hexavalent ionIBA 06/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2020
1	PlatinumIBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2019
1	N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA 01/2019
1	perlecanIBA 08/2018
1	Sulfates (Sulfates, Inorganic)IBA 08/2018
1	GSK1210151AIBA 05/2018
1	Tranexamic Acid (AMCA)FDA Link 11/2017
1	HDL LipoproteinsIBA 03/2017
1	Apoprotein(a) (Apolipoprotein (a))IBA 03/2017
1	CholesterolIBA 03/2017
1	Triglycerides (Triacylglycerol)IBA 03/2016
1	LipidsIBA 03/2016
1	human CCN6 proteinIBA 01/2016
1	Tuberculin (PPD)IBA 01/2016

Therapy/Procedure

7	Therapeutics 12/2022 - 12/2013
6	Knee Replacement Arthroplasty (Total Knee Replacement) 04/2020 - 12/2013
6	Arthroplasty 02/2018 - 01/2011
6	Hip Replacement Arthroplasty (Total Hip Replacement) 03/2016 - 01/2011
4	Orthopedic Procedures 02/2022 - 01/2013
3	Intra-Articular Injections 01/2021 - 02/2015
1	Prostheses and Implants (Prosthesis) 02/2022
1	Replacement Arthroplasty 02/2022
1	Aftercare (After-Treatment) 07/2021
1	Topical Administration 11/2017
1	Osteotomy 07/2017
1	Posterior Cruciate Ligament Reconstruction 06/2017
1	Pain Management 01/2017
1	Blood Transfusion (Blood Transfusions) 01/2016